VOORHEES — Philadelphia Flyers general Chuck Fletcher says he expects center Nolan Patrick to return from a migraine disorder and play this season.

Patrick, the No. 2 overall pick of the 2017 draft, has been sidelined all season because of his condition. The 21-year-old Patrick has 26 goals and 61 points in two seasons with the Flyers. Fletcher said Patrick has been skating for longer and harder sessions and would likely need a conditioning stint in the AHL before he returned to the Flyers.

“I can just tell you from the on- and off-ice workouts he’s doing, he is progressing,” Fletcher said Tuesday.

“There certainly isn’t any clear path as to which way this will go.”

The Flyers remain unsure when Oskar Lindblom will play again as he undergoes treatment for Ewing’s sarcoma, a cancerous tumor that grows in the bones or in the tissue around bones. The 23-year-old from Sweden had 11 goals and 18 points in 30 games this season. Lindblom has 30 goals in 134 career games over two-plus seasons with the Flyers.

“For him to return to play hockey means he’s in a great spot in his battle,” Fletcher said. “We’re just keeping our hopes up. I’m sure he’s got a lot of things on his mind right now, but if he’s playing hockey this year, that would be a great conclusion.”

Lindblom has visited his Flyers teammates during practice and sat courtside at a recent 76ers game. Lindblom has yet to speak publicly since his early December diagnosis.

“With this situation like this, when it’s your personal health and a nonhockey thing, you always want to be a little bit careful what you say, but you know the treatments are going well, and I know he’s got a great attitude,” Fletcher said.

“But it’s probably pretty early in the process to have that type of update. At some point, certainly, depending on what Oskar’s thoughts are, hopefully we can make that available.”

Can't get enough High School sports? Get the latest scores, game highlights and analysis delivered to your inbox each week

* I understand and agree that registration on or use of this site constitutes agreement to its user agreement and privacy policy.

Copyright 2020 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.

PLEASE BE ADVISED: Soon we will no longer integrate with Facebook for story comments. The commenting option is not going away, however, readers will need to register for a FREE site account to continue sharing their thoughts and feedback on stories. If you already have an account (i.e. current subscribers, posting in obituary guestbooks, for submitting community events), you may use that login, otherwise, you will be prompted to create a new account.

Load comments